Cerenome (PSTV) Assets (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Assets of $19.9 million for Q1 2026, up 65.2% year-over-year from $12.1 million in Q1 2025, and up 22.0% quarter-over-quarter from $16.3 million in Q4 2025.
Cerenome (PSTV) Assets (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Assets for 17 consecutive years, with $19.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 65.2% year-over-year to $19.9 million; the TTM figure through Mar 2026 stood at $19.9 million (up 65.2% YoY), while the FY2025 annual figure was $16.3 million, up 146.12% from the prior year.
- Assets improved to $19.9 million in Q1 2026 per PSTV's latest filing, from $16.3 million in the prior quarter.
- Across five years, Assets topped out at $24.5 million in Q1 2022 and bottomed at $5.6 million in Q1 2024.
- Historically, Assets has averaged $15.0 million across 5 years, with a median of $14.2 million in 2023.
- Annual changes were most pronounced in 2024 — Assets sank 64.06% — and 2025, when it soared 167.56%.
- Plus Therapeutics' Assets stood at $23.9 million in 2022, then plunged by 52.29% to $11.4 million in 2023, then slumped by 41.75% to $6.6 million in 2024, then jumped by 146.12% to $16.3 million in 2025, then climbed by 22.0% to $19.9 million in 2026.
- Business Quant data shows PSTV's Assets at $19.9 million in Q1 2026, $16.3 million in Q4 2025, and $18.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 14.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.92 Mn |
| Dec 31, 2025 | 16.33 Mn |
| Sep 30, 2025 | 18.67 Mn |
| Jun 30, 2025 | 10.35 Mn |
| Mar 31, 2025 | 12.06 Mn |
| Dec 31, 2024 | 6.63 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 11.21 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 11.39 Mn |
| Sep 30, 2023 | 13.28 Mn |
| Jun 30, 2023 | 14.20 Mn |
| Mar 31, 2023 | 15.64 Mn |
| Dec 31, 2022 | 23.87 Mn |
| Sep 30, 2022 | 23.10 Mn |
| Jun 30, 2022 | 21.27 Mn |
| Mar 31, 2022 | 24.52 Mn |
| Dec 31, 2021 | 21.98 Mn |
| Sep 30, 2021 | 24.75 Mn |
| Jun 30, 2021 | 20.83 Mn |